PRCT - NASDAQ
PROCEPT BioRobotics Corporation
$26.33
-1.6%PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
At a Glance
Live SnapshotPROCEPT BioRobotics Corporation Management Team
Ms. Stacey L. Porter
Chief People Officer
Ms. Alaleh Nouri
EVice President, Chief Legal Officer & Corporate Secretary
Compensation
$689,720
Mr. Hisham Shiblaq
Executive Vice President & Chief Commercial Officer
Compensation
$750,250
Mr. Kevin Waters
Executive Vice President & Chief Financial Officer
Compensation
$764,100
Mr. Barry Templin
Executive Vice President of Technology & Clinical Development
Dr. Reza Zadno Ph.D.
President, Chief Executive Officer & Director
Compensation
$1,311,550
Mr. Mohan F. Sancheti
Senior Vice President of Operations
Mr. Bijesh Chandran
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. Matthew James Bacso C.F.A.
Vice President of Investor Relations
PROCEPT BioRobotics Corporation Insider Positioning
During the last 12 months, insiders have purchased $13.47M and sold $465K worth of PRCT shares, resulting in $13.00M of net buying activity.
3 Months
1.3K
33.04K
6.1K
157.58K
-125K
-$125K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
339.6K
13.43M
4.9K
307.40K
+13.1M
+$13.13M
Top Buyers
Wood Larry L
Director, Officer: President, Ceo
$12.65M
Moll Frederic H
Director
$785K
Desai Antal Rohit
Director
$33K
Top Sellers
Desai Antal Rohit
Director
$307K
Nouri Alaleh
Officer: Evp, Clo, Corp. Sec.
$158K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $13.00M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
3 insider buyers vs. 2 sellers. More insiders buying than selling indicates positive sentiment.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
PRCT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 09, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 25, 2025 | June 10, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 22, 2024 | April 22, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 26, 2023 | April 26, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 28, 2022 | April 28, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.